Patent · US Active

SSH-2 (slingshot-2) inhibitors and methods for making and using them

US9487522B2 · kind B2 · utility

0Cited by
0References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2012
Grant dateNov 8, 2016
Priority date
Expiry dateMay 4, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/1271
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

In alternative embodiments, the invention provides compositions that inhibit the polypeptide SSH-2, or SlingSHot-2, a phosphatase enzyme that regulates actin filaments, and methods for making and using them, including methods comprising administering compositions of the invention to regulate or modify actin filament polymerization by inhibiting SSH-2, where in one embodiment compositions of the invention slow or inhibit F-actin depolymerization and severing. In alternative embodiments, compositions and methods of the invention are used to slow or inhibit cell motility and/or internal remodeling. In alternative embodiments, compositions and methods of the invention are used to slow or inhibit, or reverse, or ameliorate the progression of a cancer or a metastasis or other uncontrolled or unregulated cell growth, and/or Alzheimer's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.